Loading clinical trials...

Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2) | Clinical Trials | Clareo Health

COMPLETED

Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)

Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen by the Assessment of the Relationship Between the Symptom Scores and Global Rating of Change Questionnaires on the Quality of Life and Well-being.

NCT01953471•Hopital Foch

View on ClinicalTrials.gov

Summary

Prospective multi-center study carried out in France involving patients with allergic rhinitis. Study in usual care where no specific diagnostic or therapeutic procedure is required. The patients will be asked to fill in Questionnaires on a daily and weekly basis.

Eligibility

Age

6 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Male or female patients aged between 6 and 65 years.
•Patients who have been informed of the nature and aims of the study and have given their written consent to participate in this study in accordance with local laws and requirements.
•Patient with an Grass pollen-related allergic rhinitis (immunologically and / or symptomatically treated or non treated).
•Patients presented for symptomatic management of allergic rhinitis.
•Patients having Symptoms score ≥ 6.

Exclusion Criteria

•Patients involved in any other clinical/observational study.
•patients unable to fill in the study questionnaires.
•Patient suffering from any diagnosed disease that may interfere with the evaluation of allergic rhinoconjunctivitis' related quality of life, fatigue and daily activities.
•Patients treated with any drug that may influence the patient's fatigue and/or interfere with psychomotor performance.
•Patients suffering from persistent asthma, or asthma exacerbation during grass pollen season.

Locations (1)

Hopital Foch

Suresnes, Île-de-France Region, France

Key Dates

Start Date

April 1, 2011

Primary Completion Date

September 1, 2011

Completion Date

December 1, 2011

Last Updated

November 3, 2016

Enrollment

959

ACTUAL participants

Conditions

Allergic Rhinitis Due to Grass Pollen

Interventions

Allergic rhinitis

OTHER

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

NCT06061848

Allergic Rhinitis Due to Grass Pollen

View study

COMPLETEDPHASE3

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy

NCT05191186

Allergic Rhinitis Due to Grass PollenAllergic Conjunctivitis of Both Eyes+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 3, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)

Inclusion Criteria

Exclusion Criteria

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis